Cruciate Ligament RuptureNCT04592367
Reconstruction of the Anterior Cruciate Ligament(ACL-R) in the 30+-Year Old Assessed by Patient Reported Outcome Measures(PRO) Using the Nationwide Danish Knee Ligament Reconstruction Registry
An observational study of Cruciate Ligament Rupture, run by Region Zealand at 1 site in Denmark.
Trial summary
The purpose of the study is to evaluate the efficacy of primary ACL-R in patients 30 years of age or older using PRO. The PRO used are Knee Osteoarthritis Outcome Score(KOOS) and Tegner score. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Cruciate Ligament Rupture
- What is being tested?
- Patient age at time of procedure of reconstruction of ACL
- Type of treatment
- Surgery or procedure
- How many people
- 30,487 participants
- Where
- 1 siteDenmark
- Study dates
- 1 Jan 2005to 31 Dec 2018
- How long will I take part?
- 1 Year
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: The study population is the entire Danish population. The completeness of registry, the epidemiology of ACL-rupture and ACL-R decides the composition of the cohort.
Who may be able to join
- Patients receiving primary reconstruction of the ACL in the period 1st of January 2005 to 31st of December 2018
Who cannot join
- Multi Ligament Surgery
- Revision surgery of ACL
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Rekonstruktion af Forreste korsbånd Hos +30-årige Vurderet Ved Patient Reported Outcome Measures(PRO)
The purpose of the study is to evaluate the efficacy of primary ACL-R in patients 30 years of age or older using PRO. The PRO used are Knee Osteoarthritis Outcome Score(KOOS) and Tegner score. The Danish Knee Ligament Reconstruction Registry has data including more than 31,000 primary ACL-R performed in the period from 2005 to 2018, of which approximately a little less than 40% are performed in patients 30 years or older.
Traditionally, ACL-R has been used for the active, younger patients with the purpose of returning to their pre-injury level of activity. The increasing activity level and the desire to stay active among some patients in their fourth decade, and later, possibly increases the demands of the reconstructed ACL in this group. The aim is to investigate the PRO in this group of patients and compare them with the PRO of patients younger than 30 years of age. The study may help orthopedic surgeons counselling patients 30 years of age or older when deciding to perform an ACL-R.
The study's hypothesis is, that the overall benefit from ACL-R is equal but the patients 30 years of age or older has a worse baseline and as an implication of that worse PRO one year after the ACL-R.
Read the detailed description
Quality Assurance Plan: Clinical data reported by orthopedic surgeons at public and private hospitals, while patients undergoing ACL-R report PRO.
Source Data Verification with the Danish National Central Person Registry. Degree of completeness compared to Central Person Registry is approximately 85%.
Data dictionary provided by the data manager at RKKP - "Regionernes Kliniske Kvalitetudviklingsprogram" - Regional Clinical Quality Development Program. Patients are recruited when the ACL-R is performed, and approximately 35% report PRO 1 year after surgery. Data collection, data management and the extract from the Danish Knee Ligament Reconstruction Registry is performed by the Regional Clinical Quality Development Program. Data analysis done with support from statistician from "Region Sjælland" - Region Zealand. Sample Size Assessment not done. The cohort size is the largest we can get from the registry. The estimated number of patients 30 years of age or older with complete PROs is 2,600 men and 1,600 women. This estimation is based on the numbers from the annual report of 2019 from the Danish Knee Ligament Reconstruction Register, which states that 7,368 men and 4,656 women 30 years of age or older has undergone the procedure from 2005-2018. We expect that they report PROs as frequently as the entire cohort, which is approximately 35%. Patients with missing data will be described in table 3 and not used in table 2.
The study will present five tables.
Flowchart: Cohort size, excluded patients, patients with missing values, patients in each age group
Table 1: Descriptive statistics of the cohort with reported PRO stratified in three strata (0-14 years of age, 15-29 years of age or 30 years of age or older) with information about gender, age, previous surgery in the knee, activity at time of injury, operational technique and cartilage and meniscal status.
Table 2: Unpaired t-test if data shows normal distribution, otherwise Mann-Whitney, by change in KOOS from before surgery to one year after surgery, overall KOOS one year after surgery, Tegner one year after surgery, and Tegner from preoperatively to one year after surgery
Table 3: Descriptive statistics of population lost during follow-up
Table 4: Multivariate analysis for primary outcome
Sampling Method: Consecutive patients. Patients are enrolled into the registry when the ACL-R is performed. The completeness of registry depends on physicians' reporting of pre-, intra- and postoperative findings and patients' reporting of PROs.
- Conditions
- Cruciate Ligament Rupture
- Being tested
- Patient age at time of procedure of reconstruction of ACL
- Keywords
- ACL,, PRO, PROM, age
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Patient age at time of procedure of reconstruction of ACLProcedure or surgery
Primary reconstruction of ACL with no other concomitant ligament reconstructions. Treatment of cartilage og meniscal injury may be a part of the procedure
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in KOOS
Measured: From before surgery, but after injury, to one year after surgery
Secondary outcomes (3)
Total KOOS
Measured: One year after surgery
Total Tegner score
Measured: One year after surgery
Change in Tegner score
Measured: From before surgery, but after injury, to one year after surgery
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Oct 2020
- Study start1 Jan 2005
- Primary completion31 Dec 2018
- Study completion31 Dec 2018
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Cruciate Ligament RuptureStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 30,487 participants (actual)
- Target duration
- 1 Year
Sponsor and investigators
- Lead sponsor
- Region Zealand
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Jesper Glerup, Region Zealand
- Investigators
- Jesper Glerup, Medical Student, Principal investigator, Region ZealandJakob Klit, MD, PhD, Associate Professor, Principal investigator, Region Zealand
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04592367
- Sponsor's protocol ID
- PRO-4ACL
- Status last verified
- Oct 2020
- First submitted
- 12 Oct 2020
- Last updated
- 19 Oct 2020
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 19 Oct 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Rekonstruktion af Forreste korsbånd Hos +30-årige Vurderet Ved Patient Reported Outcome Measures(PRO)
- ClinicalTrials.gov ID
- NCT04592367
- Acronym / sponsor ID
- PRO-4ACL
- Conditions
- Cruciate Ligament Rupture
- Keywords
- ACL,, PRO, PROM, age
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 30,487 participants (actual)
- Lead sponsor
- Region ZealandUniversity, hospital or other
- Study start
- 1 Jan 2005 (actual)
- Primary completion
- 31 Dec 2018 (actual)
- Study completion
- 31 Dec 2018 (actual)
- First posted
- 19 Oct 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of the study is to evaluate the efficacy of primary ACL-R in patients 30 years of age or older using PRO. The PRO used are Knee Osteoarthritis Outcome Score(KOOS) and Tegner score. The Danish Knee Ligament Reconstruction Registry has data including more than 31,000 primary ACL-R performed in the period from 2005 to 2018, of which approximately a little less than 40% are performed in patients 30 years or older.
Traditionally, ACL-R has been used for the active, younger patients with the purpose of returning to their pre-injury level of activity. The increasing activity level and the desire to stay active among some patients in their fourth decade, and later, possibly increases the demands of the reconstructed ACL in this group. The aim is to investigate the PRO in this group of patients and compare them with the PRO of patients younger than 30 years of age. The study may help orthopedic surgeons counselling patients 30 years of age or older when deciding to perform an ACL-R.
The study's hypothesis is, that the overall benefit from ACL-R is equal but the patients 30 years of age or older has a worse baseline and as an implication of that worse PRO one year after the ACL-R.
Detailed description
Quality Assurance Plan: Clinical data reported by orthopedic surgeons at public and private hospitals, while patients undergoing ACL-R report PRO.
Source Data Verification with the Danish National Central Person Registry. Degree of completeness compared to Central Person Registry is approximately 85%.
Data dictionary provided by the data manager at RKKP - "Regionernes Kliniske Kvalitetudviklingsprogram" - Regional Clinical Quality Development Program. Patients are recruited when the ACL-R is performed, and approximately 35% report PRO 1 year after surgery. Data collection, data management and the extract from the Danish Knee Ligament Reconstruction Registry is performed by the Regional Clinical Quality Development Program. Data analysis done with support from statistician from "Region Sjælland" - Region Zealand. Sample Size Assessment not done. The cohort size is the largest we can get from the registry. The estimated number of patients 30 years of age or older with complete PROs is 2,600 men and 1,600 women. This estimation is based on the numbers from the annual report of 2019 from the Danish Knee Ligament Reconstruction Register, which states that 7,368 men and 4,656 women 30 years of age or older has undergone the procedure from 2005-2018. We expect that they report PROs as frequently as the entire cohort, which is approximately 35%. Patients with missing data will be described in table 3 and not used in table 2.
The study will present five tables.
Flowchart: Cohort size, excluded patients, patients with missing values, patients in each age group
Table 1: Descriptive statistics of the cohort with reported PRO stratified in three strata (0-14 years of age, 15-29 years of age or 30 years of age or older) with information about gender, age, previous surgery in the knee, activity at time of injury, operational technique and cartilage and meniscal status.
Table 2: Unpaired t-test if data shows normal distribution, otherwise Mann-Whitney, by change in KOOS from before surgery to one year after surgery, overall KOOS one year after surgery, Tegner one year after surgery, and Tegner from preoperatively to one year after surgery
Table 3: Descriptive statistics of population lost during follow-up
Table 4: Multivariate analysis for primary outcome
Sampling Method: Consecutive patients. Patients are enrolled into the registry when the ACL-R is performed. The completeness of registry depends on physicians' reporting of pre-, intra- and postoperative findings and patients' reporting of PROs.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 1 Year
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- The study population is the entire Danish population. The completeness of registry, the epidemiology of ACL-rupture and ACL-R decides the composition of the cohort.
Key inclusion criteria (1 listed)
- Patients receiving primary reconstruction of the ACL in the period 1st of January 2005 to 31st of December 2018
Key exclusion criteria (2 listed)
- Multi Ligament Surgery
- Revision surgery of ACL
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Patient age at time of procedure of reconstruction of ACLPrimary reconstruction of ACL with no other concomitant ligament reconstructions. Treatment of cartilage og meniscal injury may be a part of the procedure | Procedure or surgery | – |
Primary outcome
Change in KOOS
Time frame: From before surgery, but after injury, to one year after surgery
3 secondary outcomes
Total KOOS
Time frame: One year after surgery
Total Tegner score
Time frame: One year after surgery
Change in Tegner score
Time frame: From before surgery, but after injury, to one year after surgery
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Oct 2020.
- Individual participant dataSharing planned: No
Related trials for Cruciate Ligament Rupture
Not yet recruiting
Supporting Athletes' Return to Sports After ACL Reconstruction: A Study of a Psychological Readiness Program
Anterior Cruciate Ligament Reconstruction, Anterior Cruciate Ligament Injuries
Not yet recruiting
Clinical and Biological Outcomes of BioBrace-Augmented ACL Reconstruction
Anterior Cruciate Ligament Injuries, Anterior Cruciate Ligament Rupture
Not yet recruitingPhase 3
Extended Post-Operative Oral Tranexamic Acid Dosing After ACL Reconstruction
Anterior Cruciate Ligament Injuries, Anterior Cruciate Ligament Rupture
RecruitingPhase 2
Preventing Injured Knees From osteoArthritis: Severity Outcomes
Osteoarthritis, Knee, Post-traumatic Osteoarthritis
Recruiting
Quadriceps Strengthening ACL Reconstruction
ACL Tear
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Jesper Glerup, Medical Student principal investigator
Region Zealand
Jakob Klit, MD, PhD, Associate Professor principal investigator
Region Zealand
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Cruciate Ligament Rupture, run by Region Zealand at 1 site in Denmark.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 19 Oct 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in KOOS (time frame: From before surgery, but after injury, to one year after surgery). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Oct 2020.